ALNY logo

ALNY

Alnylam Pharmaceuticals Inc.

$446.51
-$5.82(-1.29%)
68
Overall
40
Value
100
Tech
65
Quality
Market Cap
$59.14B
Volume
827.61K
52W Range
$205.87 - $469.81
Target Price
$436.15
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$41.1M$47.2M$89.9M$74.9M$219.8M$854.4M$1.5B$1.0B$1.8B$2.2B
Total Revenue
$41.1M$47.2M$89.9M$74.9M$219.8M$492.9M$844.3M$1.0B$1.8B$2.2B
COST OF GOODS SOLD
Cost of Revenue
----$590.0M$1.8M$25.1M$74.2M$140.1M$168.8M$268.2M$306.5M
GROSS PROFIT
Gross Profit
$41.1M$47.2M$89.9M$73.1M$194.7M$418.7M$704.1M$868.6M$1.6B$1.9B
OPERATING EXPENSES
Operating Expenses
$337.1M$471.7M$590.0M$887.8M$1.1B$1.2B$1.4B$1.7B$1.8B$2.1B
Research & Development
$276.5M$382.4M$390.6M$505.4M$655.1M$654.8M$792.2M$883.0M$1.0B$1.1B
Research Expense
$276.5M$382.4M$390.6M$505.4M$655.1M$654.8M$792.2M$883.0M$1.0B$1.1B
Selling, General & Administrative
$60.6M$89.4M$199.4M$382.4M$479.0M$588.4M$620.6M$770.7M$795.6M$975.5M
Selling & Marketing Expenses
----------------$12.4M$29.7M
General & Administrative Expenses
$60.6M$89.4M$199.4M$382.4M$479.0M$588.4M$620.6M$770.7M$795.6M$975.5M
Promotion & Advertising
----------------$12.4M$29.7M
Salaries & Wages
$45.8M$75.5M$92.8M$157.8M$3.4M$571.0K$3.3M$230.6M$221.7M$272.1M
Depreciation & Amortization
$6.7M$9.6M$11.9M$12.8M$16.6M$30.2M$36.8M$39.1M$51.6M$55.1M
Depreciation & Amortization
$6.7M$9.6M$11.9M$12.8M$16.6M$30.2M$36.8M$39.1M$51.6M$55.1M
Other Operating Expenses
$337.1M$471.7M$-590.0M--$53.8M$53.3M$63.6M$63.4M$66.6M$-4.6M
OPERATING INCOME
Operating income
$-296.0M$-424.6M$-500.1M$-814.7M$-939.4M$-828.4M$-708.7M$-785.1M$-282.2M$-176.9M
EBITDA
$-271.0M$-395.0M$-490.9M$-760.7M$-848.1M$-696.7M$-619.4M$-929.9M$-433.5M$-377.4M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----------$84.5M$143.0M$156.0M$121.2M--
Intinc
--------$33.4M$11.8M$1.6M$24.8M$95.6M$122.0M
Net Non-Operating Interest Income/Expense
----$12.2M--$33.4M$-72.7M$-143.0M$131.2M$95.6M$122.0M
Gain on Sale of Securities
$5.9M$8.3M$12.2M$29.3M$33.4M----------
Other Income/Expense
$-5.9M$-14.5M$-9.2M$-33.4M$-20.7M$-45.5M$471.0K$-210.8M$125.7M$180.6M
Other Special Charges
$76.0K$6.2M$-3.0M$4.2M$20.7M$45.5M$-471.0K$-210.8M$-125.7M$-180.6M
SPECIAL ITEMS
Special Income Charges
------$20.6M------------
PRE-TAX INCOME
EBIT
$-290.1M$-410.1M$-490.9M$-760.7M$-885.3M$-771.1M$-709.1M$-971.0M$-433.5M$-377.4M
Pre-Tax Income
$-290.1M$-410.1M$-490.9M$-760.7M$-885.3M$-855.6M$-852.1M$-1.1B$-433.5M$-377.4M
INCOME TAX
Tax Provision
------$823.0K$863.0K$2.7M$680.0K$4.2M$6.7M$-99.2M
NET INCOME
Net Income
$-290.1M$-410.1M$-490.9M$-761.5M$-886.1M$-858.3M$-852.8M$-1.1B$-440.2M$-278.2M
Net Income (Continuing Operations)
$-290.1M$-410.1M$-490.9M$-761.5M$-886.1M$-858.3M$-852.8M$-1.1B$-440.2M$-278.2M
Net Income (Discontinued Operations)
$-290.1M$-410.1M$-490.9M$-761.5M$-886.1M$-858.3M$-852.8M$-1.1B$-440.2M$-278.2M
Net Income (Common Stockholders)
$-290.1M$-410.1M$-490.9M$-761.5M$-886.1M$-489.0M$-852.8M$-1.1B$-440.2M$-278.2M
Normalized Income
$-188.5M$-266.6M$-319.1M$-621.5M$-699.3M$-675.9M------$-476.6M
TOTALS
Total Expenses
$337.1M$471.7M$1.2B$889.6M$1.2B$1.3B$1.5B$1.8B$2.1B$2.4B
SHARE & EPS DATA
Average Shares Outstanding
$84.0M$85.6M$90.6M$100.6M$109.3M$115.0M$118.5M$121.7M$124.9M$127.7M
Average Shares Outstanding (Diluted)
$84.0M$85.6M$90.6M$100.6M$109.3M$115.0M$118.5M$121.7M$124.9M$127.7M
Shares Outstanding
$85.1M$86.0M$99.9M$106.3M$112.6M$117.0M$131.1M$124.1M$125.9M$129.5M
Basic EPS
$-3.45$-4.79--$-7.57$-8.11$-7.46$-7.2$-9.3$-3.52$-2.18
Basic EPS (Continuing Operations)
$-3.45$-4.79--$-7.57$-8.11$-7.46$-7.2$-9.3$-3.52$-2.18
Diluted EPS
$-3.45$-4.79$-5.42$-7.57$-8.11$-7.46$-7.2$-9.3$-3.52$-2.18
Diluted EPS (Continuing Operations)
------------$-7.2$-9.3$-3.52$-2.18
OTHER METRICS
Non Recurring Operation Expense
------$-20.6M------------
Other Gand A
$60.6M$89.4M$199.4M$382.4M$479.0M$588.4M$620.6M$770.7M$795.6M$975.5M
Rent And Landing Fees
$10.5M$15.9M$18.7M$40.6M$52.4M----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ALNY$446.51-1.3%827.61K
3
4
5
6

Get Alnylam Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.